![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Cambrex Charles City, Inc. Charles City Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their significant offerings is Nicotine resinate, Nicotine content 20%, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2008-171 - Rev 02
This Chemical Type CEP, issued on July 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1792 associated with this CEP further emphasizes